id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-4853-0004,FDA,FDA-2017-N-4853,Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant,Notice,Notice of Publication,2022-02-10T05:00:00Z,2022,2,2022-02-10T05:00:00Z,,2022-02-10T14:21:09Z,2022-02799,0,0,0900006484f696c0